Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Merck
Express Scripts
McKinsey
Mallinckrodt

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR RESTASIS

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Restasis

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00348335 Efficacy of Topical Cyclosporin for Ocular Rosacea Completed Allergan Phase 4 2006-06-01 The purpose of this study is to determine whether Restasis (topical cyclosporin) is effective in the treatment of ocular rosacea
NCT00348335 Efficacy of Topical Cyclosporin for Ocular Rosacea Completed Ophthalmic Consultants of Long Island Phase 4 2006-06-01 The purpose of this study is to determine whether Restasis (topical cyclosporin) is effective in the treatment of ocular rosacea
NCT00349440 Efficacy of Cyclosporine for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive Keratectomy Completed Innovative Medical Phase 4 2006-09-01 The purpose of this study is to evaluate the effect of topical cyclosporine ophthalmic solution 0.05% (Restasis, Allergan) on the signs and symptoms of dry eye in patients undergoing LASIK or photorefractive keratectomy (PRK).
NCT00399061 Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye Symptoms Completed Innovative Medical Phase 4 2006-11-01 The purpose of this study is to evaluate the efficacy of Optive versus Systane used concomitantly with topical cyclosporine for the treatment of dry eye.
NCT00405431 Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery? Completed Allergan N/A 2004-03-01 The purpose of this study is to determine whether reducing inflammation of the surface of the eye with topical Restasis after glaucoma surgery will improve surgical outcomes and increase patient comfort.
NCT00405431 Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery? Completed Wills Eye N/A 2004-03-01 The purpose of this study is to determine whether reducing inflammation of the surface of the eye with topical Restasis after glaucoma surgery will improve surgical outcomes and increase patient comfort.
NCT00405457 Efficacy and Safety of a New Multi-dose Lubricant Eye Drop Concomitant With Restasis® (Cyclosporine A) for the Treatment of Dry Eye Symptoms Completed Innovative Medical Phase 4 2006-11-01 To evaluate the efficacy, safety and tolerability of a combination of Optive® Artificial Tears with Restasis®.The primary hypothesis is that the Ocular Surface Disease Index (OSDI) score and symptoms will be the same or lower than baseline after treatment in these patients. The patients will tolerate the combination of Restasis® and Optive® with a low incidence of clinical adverse events.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Restasis

Condition Name

Condition Name for Restasis
Intervention Trials
Dry Eye Syndromes 11
Dry Eye 7
Dry Eye Syndrome 5
Keratoconjunctivitis Sicca 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Restasis
Intervention Trials
Keratoconjunctivitis Sicca 27
Dry Eye Syndromes 27
Syndrome 9
Eye Diseases 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Restasis

Trials by Country

Trials by Country for Restasis
Location Trials
United States 37
Korea, Republic of 6
Thailand 2
Singapore 2
India 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Restasis
Location Trials
California 6
New York 4
Massachusetts 4
Tennessee 3
Texas 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Restasis

Clinical Trial Phase

Clinical Trial Phase for Restasis
Clinical Trial Phase Trials
Phase 4 14
Phase 3 8
Phase 2 10
[disabled in preview] 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Restasis
Clinical Trial Phase Trials
Completed 28
Recruiting 5
Unknown status 3
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Restasis

Sponsor Name

Sponsor Name for Restasis
Sponsor Trials
Allergan 11
Innovative Medical 6
Huons Co.,Ltd. 3
[disabled in preview] 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Restasis
Sponsor Trials
Industry 30
Other 22
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Colorcon
Johnson and Johnson
Mallinckrodt
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.